Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model
View/ Open
Author
Obaldía III, Nicanor
Dow, Geoffrey S.
Gerena, Lucia
Kyle, Dennis
Otero, William
Mantel, Pierre-Yves
Baro, Nicholas
Buckee, Caroline
Volkman, Sarah K.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1038/srep21216Metadata
Show full item recordCitation
Obaldía III, N., G. S. Dow, L. Gerena, D. Kyle, W. Otero, P. Mantel, N. Baro, et al. 2016. “Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model.” Scientific Reports 6 (1): 21216. doi:10.1038/srep21216. http://dx.doi.org/10.1038/srep21216.Abstract
Infections with Plasmodium falciparum, the most pathogenic of the Plasmodium species affecting man, have been reduced in part due to artemisinin-based combination therapies. However, artemisinin resistant parasites have recently emerged in South-East Asia. Novel intervention strategies are therefore urgently needed to maintain the current momentum for control and elimination of this disease. In the present study we characterize the phenotypic and genetic properties of the multi drug resistant (MDR) P. falciparum Thai C2A parasite strain in the non-human Aotus primate model, and across multiple passages. Aotus infections with C2A failed to clear upon oral artesunate and mefloquine treatment alone or in combination, and ex vivo drug assays demonstrated reduction in drug susceptibility profiles in later Aotus passages. Further analysis revealed mutations in the pfcrt and pfdhfr loci and increased parasite multiplication rate (PMR) across passages, despite elevated pfmdr1 copy number. Altogether our experiments suggest alterations in parasite population structure and increased fitness during Aotus adaptation. We also present data of early treatment failures with an oral artemisinin combination therapy in a pre-artemisinin resistant P. falciparum Thai isolate in this animal model.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754742/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:25658525
Collections
- FAS Scholarly Articles [18292]
- SPH Scholarly Articles [6362]
Contact administrator regarding this item (to report mistakes or request changes)